These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27688072)

  • 1. Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles.
    Schmidt T; Leha A; Salinas-Riester G
    Gene; 2016 Dec; 595(2):161-167. PubMed ID: 27688072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo.
    Shukeir N; Stefanska B; Parashar S; Chik F; Arakelian A; Szyf M; Rabbani SA
    Br J Pharmacol; 2015 Jun; 172(11):2769-81. PubMed ID: 25631332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth.
    Da MX; Zhang YB; Yao JB; Duan YX
    Braz J Med Biol Res; 2014 Dec; 47(12):1021-8. PubMed ID: 25387667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
    Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
    Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer.
    Hussain Z; Khan MI; Shahid M; Almajhdi FN
    Genet Mol Res; 2013 Apr; 12(2):1106-18. PubMed ID: 23661436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylmethionine treatment affects histone methylation in prostate cancer cells.
    Mathes A; Duman MB; Neumann A; Dobreva G; Schmidt T
    Gene; 2024 Jan; 893():147915. PubMed ID: 37866662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression.
    Zsigrai S; Kalmár A; Nagy ZB; Barták BK; Valcz G; Szigeti KA; Galamb O; Dankó T; Sebestyén A; Barna G; Szabó V; Pipek O; Medgyes-Horváth A; Csabai I; Tulassay Z; Igaz P; Takács I; Molnár B
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
    Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
    Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].
    Yang N; Wang L; Chen X; Liu J; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-adenosylmethionine mediates inhibition of inflammatory response and changes in DNA methylation in human macrophages.
    Pfalzer AC; Choi SW; Tammen SA; Park LK; Bottiglieri T; Parnell LD; Lamon-Fava S
    Physiol Genomics; 2014 Sep; 46(17):617-23. PubMed ID: 25180283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of EphA5 by promoter methylation in human prostate cancer.
    Li S; Zhu Y; Ma C; Qiu Z; Zhang X; Kang Z; Wu Z; Wang H; Xu X; Zhang H; Ren G; Tang J; Li X; Guan M
    BMC Cancer; 2015 Jan; 15():18. PubMed ID: 25609195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo.
    Pakneshan P; Xing RH; Rabbani SA
    FASEB J; 2003 Jun; 17(9):1081-8. PubMed ID: 12773490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
    Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
    OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
    Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
    Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis.
    Mahmood N; Arakelian A; Cheishvili D; Szyf M; Rabbani SA
    J Cell Mol Med; 2020 Sep; 24(18):10322-10337. PubMed ID: 32720467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
    Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
    Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.